Hunlicar Group Limited disclosed that on 22 May 2026 it bought back 18,000 ordinary shares on the Hong Kong Stock Exchange at prices between HK$8.45 and HK$8.55, for a total consideration of HK$0.15 million. The volume-weighted average price was approximately HK$8.51 per share.
The transaction leaves the company’s issued share capital unchanged at 77.15 million ordinary shares, with no treasury shares held.
Including the latest purchase, the company has repurchased 431,000 shares under the buy-back mandate authorised on 25 September 2025, equivalent to 0.56 % of the issued shares outstanding on the mandate date. The mandate permits repurchases of up to 7.74 million shares.
Repurchased shares awaiting cancellation now total 154,000, or about 0.20 % of the current issued share capital. A moratorium on new share issues or treasury-share sales remains in force until 21 June 2026.
Comments